Effectiveness of a Digital Treatment for Adolescents with Chronic Pain
ConditionChronic Pain
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-18
SponsorUniversity Rovira i Virgili
About this trial
Research has shown that the prevalence of chronic pain in adolescents is high and increasing. These young people report significant changes in both their physical and psychological functioning. Currently, psychosocial treatments enjoy strong empirical support and are crucial to maintaining and improving the quality of life of adolescents suffering from chronic pain. However, the availability of these evidence-based interventions is insufficient to meet the high demand, especially outside of large cities. The aim of this project is to develop a digital treatment that helps improve the quality of life of adolescents with chronic pain and complementary websites for their parents and teachers.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
12-18 years old,
Having a non-oncology secondary chronic pain problem,
Having internet access,
A parent willing to participate in the study,
Disqualifiers
Cognitive or language problems
Trial design
Design model
Single group
Treatments tested in this trial
Self-administered psychosocial intervention delivered via smartphone.
BehavioralThe treatment includes a smartphone-based psychosocial program designed to improve the quality of life of adolescents with chronic pain.
Treatment groups
195 Participants
are divided into 1 treatment groupGroup A: Digital treatmentExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Pain intensity
Refers to the severity of pain an individual experiences, measured on a scale (0-10)
Time frame
baseline, 8 weeks, 3 months follow-up2
Pain interference
Refers to the extent to which pain affects an individual's daily life and functioning. Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Pain Interference will be used (0-32; 0=no interference, 32=intense interference).
Time frame
baseline, 8 weeks, 3 months follow-up3
Global perception of change after treatment
refers to an individual's overall assessment of how their condition has improved or worsened following a treatment, measured on a scale (0-10).
Time frame
8 weeks, 3 months follow-upSponsors and contacts
Click on the lead sponsor to view all of their trials.
University Rovira i Virgili
Lead sponsor
Ministry of Science and Innovation, Spain
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: